PDS Biotechnology Corporation - Common Stock (PDSB)

0.2984
+0.0784 (35.64%)
NASDAQ· Last Trade: Sep 8th, 2:44 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Defense Tech Stocks MOBX, PRSO Advance Across Fighter Jets, Military Robotics
Sept. 8, 2026 Mobix Labs Inc. (NASDAQ: MOBX) and Peraso Inc. (NASDAQ: PRSO) are gaining attention across the expanding defense technology market, with Mobix Labs securing its initial production order supporting the F-16 Fighting Falcon and Peraso positioning its 60GHz mmWave technology across military robotics, UAVs and autonomous systems .
Via AB Newswire · September 8, 2026
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · March 14, 2025
Life Sciences Investor Forum Agenda Announced for March 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · March 12, 2025
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews Dr. Frank Bedu-Addo, CEO PDS Biotechnology Corporation
NEW YORK, NY / ACCESSWIRE / December 5, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with PDS Biotechnology Corporation.
Via ACCESSWIRE · December 5, 2022
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix which is due to the abnormal growth of cells that have the ability […]
Via FinancialNewsMedia · October 6, 2022